Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034067 (
emphysema
)
11,506
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The combination of functional indices best reflecting the extent of
emphysema
is not known. High-resolution computed tomography (HRCT) studies of 106 patients with
emphysema
[men=71; median age=61 (range=26-86 years)] were reviewed and the extent of
emphysema
was quantified: (a) visually (
emphysema
(vis)) and (b) by automated estimation (
emphysema
(auto)). Functional-morphologic relationships were compared for the two scoring systems, and a composite physiologic index (CPI) (providing the best fit of functional indices against
emphysema
extent) was derived.
Emphysema
(vis) and
emphysema
(auto) were strongly correlated (r=0.90; p<0.0005), but the extent of
emphysema
(vis) was consistently greater (p<0.00005).
Emphysema
(vis) correlated most strongly with indices of gas transfer [percent predicted single-breath carbon monoxide diffusing capacity (Dl(co)) and alveolar volume (K(co)); r=-0.70, both p<0.0005]. The combination of physiologic indices most representative of
emphysema
extent on CT (using visual or automated methods) consisted of K(co) and forced expiratory volume in 1 s (
FEV
(1)) levels. The equation explanatory power was higher for visual scoring [
emphysema
(vis)=96.8-(0.67 x % predicted K(co))-(0.41 x % predicted
FEV
(1)); equation r(2)=0.57] than automated estimation (equation r(2)=0.48). Weighted combinations of K(co) and
FEV
(1) levels provide a CPI best reflecting morphologic
emphysema
extent. CPI has the potential to refine the stratification of patients in epidemiological and therapeutic studies.
...
PMID:Quantification of emphysema: a composite physiologic index derived from CT estimation of disease extent. 1694 Oct 93
Gravitational deposition of monodisperse particles can be used to determine effective airway diameter (EAD). The aim of our study was to assess intraindividual variability of EAD in healthy subjects and patients with
emphysema
, to compare EAD in patients with different degree and type of
emphysema
, and to evaluate whether parametric or model analysis would improve the results. EAD was measured vs volumetric lung depth (LD) in 11 healthy subjects (
FEV
subset1 107%pred) and 41 patients with
emphysema
(
FEV
subset1 60%pred; 8/9/24 mild/moderate/severe, 18/7/16 centriacinar/panacinar/bullous according to HRCT). Repeated measurements in LDs of 6-30% showed coefficients of variation of 7.0-10.4% in healthy subjects and 8.3-11.9% in
emphysema
. Average EAD in 10-16% LD was increased in
emphysema
, in particular moderate and severe (p<0.05, each). The slope of EAD in 10-16% LD differed between healthy subjects and
emphysema
, especially bullous and centriacinar. Patients with severe
emphysema
also showed a different slope compared to mild
emphysema
and controls. The parameters of the power function used for data fitting also showed differences between controls and
emphysema
, as well as between centriacinar vs panacinar and bullous
emphysema
. In a three-compartment lung model only the diameter of the intermediate compartment was enlarged in
emphysema
. We conclude that in using aerosol-derived airway morphometry, reproducibility of repeated measurements is acceptable. Average values and slopes of the EAD curve, as well as a power function for data fitting, were sensitive in the detection of type and severity of
emphysema
. In contrast, application of a lung model did not improve the results.
...
PMID:Aerosol-derived airway morphometry (ADAM) in patients with lung emphysema diagnosed by computed tomography--reproducibility, diagnostic information and modelling. 1736 21
In patients with airflow limitation caused by cigarette smoking, lung density measured by computed tomography is strongly correlated with quantitative pathology scores of
emphysema
, but the ability of lung densitometry to detect progression of
emphysema
is disputed. We assessed the sensitivity of lung densitometry as a parameter of disease progression of
emphysema
in comparison to
FEV
(1) and gas transfer. At study baseline and after 30 months we measured computed tomography (CT)-derived lung density, spirometry and carbon monoxide diffusion coefficient in 144 patients with chronic obstructive pulmonary disease (COPD) in five different centers. Annual change in lung density was 1.31 g/L/year (CI 95%: -2.12 to -0.50 HU, p=0.0015, 39.5 mL/year (CI 95%: -100.0-21.0 mL, p=0.2) for
FEV
(1) (-39.5 mL) and 24.3 micromol/min/kPa/L/year for gas transfer (CI 95%: -61.0-12.5 micromol/min/kPa/L/year, p=0.2). Signal-to-noise ratio (mean change divided by standard error of the change) for the detection of annual change was 3.2 for lung densitometry, but 1.3 for both
FEV
(1) and gas diffusion. We conclude that detection of progression of
emphysema
was found to be 2.5-fold more sensitive using lung densitometry than by using currently recommended lung function parameters. Our results support CT scan as an efficacious test for novel drugs for
emphysema
.
...
PMID:Progression parameters for emphysema: a clinical investigation. 1764 66
A 60-year-old man presented to the Emergency Department (ED) with large, painful, indurated plaques on the right thigh, left abdomen, left chest, and right chest, which began without any preceding trauma on the right thigh 3 weeks prior to presentation in the ED. He was initially treated with cefazolin 1 g three times daily as home infusions. When the lesions continued to progress, he was admitted to the hospital and placed on amoxicillin/clavulanate and vancomycin. He had a single episode of fever of 102 degrees F, but his white blood cell count and differential remained normal. An initial biopsy showed a dermal inflammatory infiltrate composed primarily of neutrophils and eosinophils with rare flame figures in the dermis. There was minimal fat seen in this biopsy. A differential diagnosis of Wells or Sweet's syndrome was entertained, and he was placed on 60 mg/day prednisone with no resolution of his symptoms. The patient's past medical history included hypertension, hyperlipidemia, peripheral neuropathy, and hiatal hernia. His family history was significant for
emphysema
in both parents and coronary artery disease in his father. Both of his parents smoked cigarettes. His grandfather, who was a coal miner, also had
emphysema
. Whilst on antibiotics and prednisone, the plaques on the patient's right thigh, right abdomen, and left chest expanded and ulcerated, draining an oily liquid (Figs 1 and 2). An incisional biopsy was obtained from his thigh. Histopathology showed a septal and lobular panniculitis with fat necrosis, neutrophils, and histiocytes (Fig. 3). Special stains for organisms were negative. Tissue sent for bacterial and fungal culture had no growth. Amylase and lipase levels were normal. Rheumatoid factor, antinuclear antibody (ANA), antineutrophil cytoplasmic antibody (ANCA), cryoglobulins, and antiphospholipid antibodies were all normal. The alpha1-antitrypsin level was low at 25 mg/dL (ref. 75-135). The alpha1-antitrypsin phenotype was PiZZ. The patient had a normal glucose-6-phosphate dehydrogenase level and was placed on dapsone 200 mg/day. The inflammation resolved and, over the course of several months, the involved areas healed with scarring. The patient denied any pulmonary complaints but, during his hospitalization, was found incidentally to have an oxygen saturation of 88% on room air. He was sent for evaluation by a pulmonologist, and pulmonary function tests revealed a mixed restrictive and obstructive pattern with a forced expiratory volume in 1 to forced vital capacity (
FEV
(1)/FVC) ratio of 63% of predicted. He had never smoked. He was placed on supplemental oxygen but, as his pulmonary disease has been stable, he has not been treated with intravenous antitrypsin inhibitor.
...
PMID:alpha1-Antitrypsin deficiency presenting with panniculitis and incidental discovery of chronic obstructive pulmonary disease. 1791 Jul 20
Subjects with severe chronic obstructive pulmonary disease (COPD) may have marked differences in
emphysema
severity on chest computed tomography (CT) scans. Although many patients with severe COPD will have chest CTs performed during their clinical care, chest CTs have not been widely included in epidemiologic and genetic studies of COPD. We sought to determine whether chest CT scans performed for clinical indications can provide useful data in an epidemiologic study of COPD and to determine whether chest CT scans can be used to define subtypes of severe, early-onset COPD. Clinical chest CT scans on 91 probands in the Boston Early-Onset COPD Study were retrospectively reviewed by 2 pulmonologists and 1 to 2 chest radiologists, using a semi-quantitative
emphysema
severity score, ranging from 0-24. 88 of 91 chest CT scans were suitable for
emphysema
analysis. There was a wide range of
emphysema
severity, from mild to severe (1.3-23.7).
Emphysema
-predominant subjects (upper 3 quartiles of
emphysema
scores) had more severe airflow obstruction than airway-predominant subjects (lowest quartile of
emphysema
scores):
FEV
(1) 17.4% vs. 22.4% predicted, p=0.009. A higher percentage of airway-predominant subjects had a positive bronchodilator response (28.6% vs. 6.7%, p=0.009). Airway-predominant subjects also had a higher frequency of physician-diagnosed asthma (p=0.04) and a trend towards higher serum immunoglobulin E levels (p=0.09). Analysis of siblings of early-onset COPD probands suggested a genetic contribution to the subgroups. Using clinical chest CT scans, we were able to identify an airway-predominant subgroup with asthma-like features among subjects with severe, early-onset COPD.
...
PMID:Computed tomography phenotypes in severe, early-onset chronic obstructive pulmonary disease. 1802 60
Lung volume reduction surgery (LVRS) has been shown to improve lung function and exercise tolerance in patients with severe
emphysema
. Some predictors of poor outcome have been described but the role of alpha1-antitrypsin (alpha1-AT) deficiency is still not well known. The aim of this study was to analyze the results of unilateral LVRS in our center according to the alpha1-AT status. The results of LVRS in 17 deficient patients and 35 nondeficient patients were analyzed at 3-6 months and 1 year after surgery. Compared with baseline, a significant improvement of FEV1, partial pressure in arterial blood (PaO2), dyspnea score and walking distance was observed in the two groups at 3-6 months after surgery and the studied parameters remained significantly improved at 1 year in the nondeficient group. By contrast, PaO2 and walking distance returned towards baseline in the deficient group at 1 year whereas improvement of FEV1 and dyspnea score was persistent. Mean values of
FEV
, at baseline, 3-6 months, and 1 year were 22 +/- 6%, 29 +/- 11%, and 26 +/- 9% and 28 +/- 12%, 38 +/- 17%, and 40 +/- 17% predicted in the deficient group and in the non-deficient group, respectively. In conclusion, the functional benefit is short-lasting in alpha1-AT deficient patients after unilateral LVRS.
...
PMID:Functional results of unilateral lung volume reduction surgery in alpha1-antitrypsin deficient patients. 1804 97
The objectives of the present study were to reappraise chest radiography for the diagnosis of
emphysema
, using computed tomography (CT) as the reference standard, and to establish whether or not chest radiography is useful for phenotyping chronic obstructive pulmonary disease (COPD). Patients (n = 154) who had undergone posteroanterior and lateral chest radiography and CT for diagnostic purposes were studied. CT data were scored for
emphysema
using the picture-grading method. Chest radiographs were examined independently by five raters using four criteria for
emphysema
that had been validated against lung pathology. These criteria were then used to assess the prevalence of
emphysema
in 458 COPD patients. Patients with and without evidence of
emphysema
were compared with regard to age, sex, smoking history, body mass index (BMI), forced expiratory volume in one second (
FEV
(1)), diffusing capacity of the lung for carbon monoxide (D(L,CO)) and health status. Chest radiography yielded a sensitivity of 90% and a specificity of 98% for
emphysema
. Of the 458 COPD patients, 245 showed radiological evidence of
emphysema
. Emphysemic patients had a significantly lower BMI,
FEV
(1) and D(L,CO), greater restriction of physical activity and worse quality of life than nonemphysemic patients. There was no difference across the two groups with regard to age, sex or smoking history. Chest radiography is a simple means of diagnosing moderate-to-severe
emphysema
. It is useful in phenotyping chronic obstructive pulmonary disease and may aid physicians in their choice of treatment.
...
PMID:Value of chest radiography in phenotyping chronic obstructive pulmonary disease. 1805 56
The aim of this study is to clarify whether patients with chronic obstructive pulmonary disease (COPD) lose less exercise capacity after lobectomy than do those without COPD, to the same extent as ventilatory capacity and lobectomy for selected patients with severe
emphysema
improve exercise capacity like ventilatory capacity. Seventy non-COPD patients (N group), 16 mild COPD patients (M group), and 14 moderate-to-severe COPD patients (S group) participated. Pulmonary function and exercise capacity tests were performed on the same day preoperatively and six months to one year after lobectomy. The S group lost significantly less
FEV
(1) (forced expiratory volume in 1 s) after lobectomy than did the N or M group (P<0.0001 and P<0.005). However, their loss of exercise capacity was equivalent to that for the N and M groups. For the S group, there was a significant, negative correlation between preoperative
FEV
(1) % of predicted and percentage change in
FEV
(1) and maximum oxygen consumption (VO2 max) after lobectomy (r=-0.93, P<0.0001 and r=-0.64, P=0.01). In moderate-to-severe COPD patients, patients with a lower preoperative
FEV
(1) % of predicted experienced a smaller decrease in
FEV
(1) and VO2 max after lobectomy.
...
PMID:Exercise capacity after lobectomy in patients with chronic obstructive pulmonary disease. 1827 Feb 19
The severity of chronic obstructive pulmonary disease (COPD) is evaluated not only by airflow limitation but also by factors such as exercise capacity and body mass index. Recent advances in CT technology suggest that it might be a useful tool for evaluating the severity of the disease components of COPD. The aim of this study is to evaluate the correlation between the parameters measured on volumetric CT, including the extent of
emphysema
, air trapping, and airway thickening, and clinical parameters. CT scans were performed in 34 patients with COPD at full inspiration and expiration. We used in-house software to measure CT parameters, including volume fraction of
emphysema
(V(950)), mean lung density (MLD), CT air trapping index (CT ATI), segmental bronchial wall area (WA), lumen area (LA), and wall area percent (WA%). We found that the CT parameters were correlated with the pulmonary function test (PFT) results, body mass index (BMI), the modified Medical Research Council Dyspnea scale (MMRC scale), the six-minute-walk distance (6MWD), and the BODE index. V(950 insp) correlated to the BMI,
FEV
(1), 6MWD, and the BODE index. The CT ATI correlated with the physiologic ATI (VC-FVC) (R=0.345, p=0.045) and the MMRC scale (R=0.532, p=0.001). There was a positive correlation between the WA% and the BMI (R=0.563, p<0.001). MLD(exp) showed the strongest correlation with the BODE index (R= -0.756, p<0.001). We conclude that the severity of
emphysema
and air trapping measured on CT correlated with the PFT parameters 6MWD and BMI.
...
PMID:Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. 2848 70
Improved survival following extreme preterm birth complicated by bronchopulmonary dysplasia (BPD) is resulting in an increasing number of affected infants surviving to adulthood. The aim of the present pilot study was to describe the functional and structural pulmonary sequelae of moderate and severe BPD in a population of adult survivors. All babies were cared for at one institution (King Edward Memorial Hospital, Subiaco, Australia). Subjects born between 1980 and 1987 with birthweight <1,500 g and requiring supplementary oxygen at 36 weeks post-menstrual age were identified from a complete neonatal database and recruited prospectively. Local physicians were concurrently asked to refer suitable patients. Demographics, respiratory symptoms and examination results, pulmonary function tests and computed tomography images were acquired. In total, 21 subjects were studied. Of these, 12 were female, the median (range) age was 19 (17-33) yrs and 15 (71%) had persistent respiratory symptoms. The median (range) forced expiratory volume in one second (
FEV
(1)) z-score was -0.77 (-8.20-1.37), the forced expiratory flow at 25-75% of forced vital capacity was -1.81 (-6.00-0.75) and the diffusing capacity of the lung for carbon monoxide was -5.04 (-13.17- -1.24). Computed tomography was carried out on 19 subjects and all had abnormal findings, with
emphysema
being the most common, present in 84% of subjects. The extent of radiological
emphysema
was inversely related to the
FEV
(1) z-score. Young adult survivors of moderate and severe bronchopulmonary dysplasia may be left with residual functional and characteristic structural pulmonary abnormalities, most notably
emphysema
.
...
PMID:Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. 1838 72
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>